Trulieve CEO: Medical Hashish Transition | Mad Money | CNBC

Trulieve CEO: Medical Hashish Transition | Mad Money | CNBC

It’s a scientific marijuana company serving to over 80,000 sufferers and you can hold never heard of it. Jim Cramer appears to be like into Trulieve and what it will…

Read more »
Immune Gut & Brain
Cannabis firm Trulieve studies checklist earnings, nonetheless posts a earnings loss

Cannabis firm Trulieve studies checklist earnings, nonetheless posts a earnings loss

Trulieve CEO Kim Rivers discusses her firm’s checklist earnings. With CNBC’s Melissa Lee and the Like a flash Cash traders, Karen Finerman, Tim Seymour, Jeff Mills and Bonawyn Eison. For…

Read more »